Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed and Refractory Peripheral T-cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT00423826
What this trial is testing

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Looking for participantsNCT06934382
What this trial is testing

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Stephan Grupp MD PhD 33
Early research (Phase 1)Study completedNCT02181218
What this trial is testing

Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas

Who this might be right for
Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralHodgkin Disease+1 more
Washington University School of Medicine 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05464433
What this trial is testing

Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma

Who this might be right for
Extranodal Natural Killer T Cell Lymphoma
Sun Yat-sen University 46
Large-scale testing (Phase 3)WithdrawnNCT04021082
What this trial is testing

CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-Cell Lymphoma (PTCL NOS)Nodal Lymphomas of T Follicular Helper (TFH)Follicular T-cell Lymphoma (FTCL)+6 more
Portola Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Testing effectiveness (Phase 2)Study completedNCT03927105
What this trial is testing

Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
University of Michigan Rogel Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT01822886
What this trial is testing

Phase II Study of Gemcitabine+Romidepsin in the Relapsed/Refractory Peripheral T-cell Lymphoma Patients

Who this might be right for
Peripheral T-cell Lymphoma
Fondazione Italiana Linfomi - ETS 20
Early research (Phase 1)Looking for participantsNCT05079282
What this trial is testing

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Who this might be right for
Relapsed or Refractory T Cell Lymphoma
Ono Pharmaceutical Co., Ltd. 217
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01093586
What this trial is testing

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more
Case Comprehensive Cancer Center 14
Not applicableLooking for participantsNCT01137825
What this trial is testing

Registry of Older Patients With Cancer

Who this might be right for
Chronic Myeloproliferative DisordersCognitive/Functional EffectsLeukemia+6 more
UNC Lineberger Comprehensive Cancer Center 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT07018752
What this trial is testing

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas

Who this might be right for
Peripheral T Cells Lymphoma (PTCL)
The Lymphoma Academic Research Organisation 49
Testing effectiveness (Phase 2)Looking for participantsNCT06244368
What this trial is testing

GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

Who this might be right for
Peripheral T Cell LymphomaDiffuse Large B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 115
Testing effectiveness (Phase 2)Study completedNCT02927925
What this trial is testing

Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type

Who this might be right for
Lymphoma
Janssen Research & Development, LLC 32
Early research (Phase 1)Study completedNCT00338494
What this trial is testing

Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma

Who this might be right for
B-Cell Lymphoma
Yale University 16
Testing effectiveness (Phase 2)Looking for participantsNCT06874946
What this trial is testing

Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL

Who this might be right for
Precursor T-Cell Lymphoblastic Leukemia-LymphomaT - Cell LymphomaPTCL
Peking University People's Hospital 30
Not applicableEnded earlyNCT01841021
What this trial is testing

Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30

Who this might be right for
Peripheral T-Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03674411
What this trial is testing

Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaBiphenotypic/Undifferentiated Leukemia+8 more
Masonic Cancer Center, University of Minnesota 22
Early research (Phase 1)Study completedNCT01129180
What this trial is testing

Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+9 more
Pierluigi Porcu 8
Next Page